Literature DB >> 20883455

Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.

Sara Tucci1, Sonja Primassin, Ute Spiekerkoetter.   

Abstract

Hepatopathy and hepatomegaly as consequences of prolonged fasting or illnesses are typical clinical features of very long chain acyl-CoA dehydrogenase (VLCACD) deficiency, the most common long-chain fatty acid β-oxidation defect. Supplementation with medium-chain triglycerides (MCTs) is an important treatment measure in these defects, in order to supply sufficient energy. Little is known about the pathogenetic mechanisms leading to hepatopathy. Here, we investigated the effects of prolonged fasting and an MCT diet on liver function. Wild-type (WT) and VLCAD knockout mice were fed with either a regular long-chain triglyceride diet or an MCT diet for 5 weeks. In both groups, we determined liver and blood lipid contents under nonfasting conditions and after 24 h of fasting. Expression of genes regulating peroxisomal and microsomal oxidation pathways was analyzed by RT-PCR. In addition, glutathione peroxidase and catalase activities, as well as thiobarbituric acid reactive substances, were examined. In VLCAD knockout mice fed with a long-chain triglyceride diet, fasting is associated with excessive accumulation of liver lipids, resulting in hepatopathy and strong upregulation of peroxisomal and microsomal oxidation pathways as well as antioxidant enzyme activities and thiobarbituric acid reactive substances. These effects were even evident in nonfasted mice fed with an MCT diet, and were particularly pronounced in fasted mice fed with an MCT diet. This study strongly suggests that liver damage in fatty acid oxidation defects is attributable to oxidative stress and generation of reactive oxygen species as a result of significant fat accumulation. An MCT diet does not prevent hepatic damage during catabolism and metabolic derangement.
© 2010 The Authors Journal compilation © 2010 FEBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883455     DOI: 10.1111/j.1742-4658.2010.07876.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

1.  Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.

Authors:  Julien Baruteau; Philippe Sachs; Pierre Broué; Michèle Brivet; Hendy Abdoul; Christine Vianey-Saban; Hélène Ogier de Baulny
Journal:  J Inherit Metab Dis       Date:  2012-10-03       Impact factor: 4.982

2.  Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse.

Authors:  Sara Tucci; Ulrich Floegel; Frauke Beermann; Sidney Behringer; Ute Spiekerkoetter
Journal:  J Lipid Res       Date:  2016-11-24       Impact factor: 5.922

Review 3.  Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.

Authors:  Sara Tucci
Journal:  J Inherit Metab Dis       Date:  2017-02-28       Impact factor: 4.982

4.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

5.  Application of an Image Cytometry Protocol for Cellular and Mitochondrial Phenotyping on Fibroblasts from Patients with Inherited Disorders.

Authors:  Paula Fernandez-Guerra; M Lund; T J Corydon; N Cornelius; N Gregersen; J Palmfeldt; Peter Bross
Journal:  JIMD Rep       Date:  2015-09-25

6.  Dysregulation of Npas2 leads to altered metabolic pathways in a murine knockout model.

Authors:  Derek O'Neil; Hector Mendez-Figueroa; Toni-Ann Mistretta; Chunliu Su; Robert H Lane; Kjersti M Aagaard
Journal:  Mol Genet Metab       Date:  2013-09-05       Impact factor: 4.797

7.  Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Terry G J Derks; Catharina M L Touw; Graziela S Ribas; Giovana B Biancini; Camila S Vanzin; Giovanna Negretto; Caroline P Mescka; Dirk Jan Reijngoud; G Peter A Smit; Moacir Wajner; Carmen R Vargas
Journal:  J Inherit Metab Dis       Date:  2014-03-13       Impact factor: 4.982

8.  Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.

Authors:  Sara Tucci; Diran Herebian; Marga Sturm; Annette Seibt; Ute Spiekerkoetter
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

9.  Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.

Authors:  Bianca Seminotti; Guilhian Leipnitz; Anuradha Karunanidhi; Catherine Kochersperger; Vera Y Roginskaya; Shrabani Basu; Yudong Wang; Peter Wipf; Bennett Van Houten; Al-Walid Mohsen; Jerry Vockley
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

10.  Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(-/-)) mice.

Authors:  Sara Tucci; Antonia Krogmann; Diran Herebian; Ute Spiekerkoetter
Journal:  Mol Cell Pediatr       Date:  2014-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.